Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
77.65
-2.59 (-3.23%)
Mar 19, 2026, 2:15 PM EDT - Market open
Lantheus Holdings Market Cap
Lantheus Holdings has a market cap or net worth of $5.02 billion as of March 19, 2026. Its market cap has decreased by -25.37% in one year.
Market Cap
5.02B
Enterprise Value
5.27B
1-Year Change
-25.37%
Ranking
Category
Stock Price
$77.65
Market Cap Chart
Since June 25, 2015, Lantheus Holdings's market cap has increased from $178.90M to $5.02B, an increase of 2,704.16%. That is a compound annual growth rate of 36.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 5.18B | 17.47% |
| Dec 31, 2025 | 4.41B | -29.05% |
| Dec 31, 2024 | 6.22B | 46.48% |
| Dec 29, 2023 | 4.25B | 21.06% |
| Dec 30, 2022 | 3.51B | 79.37% |
| Dec 31, 2021 | 1.96B | 116.78% |
| Dec 31, 2020 | 902.10M | 12.06% |
| Dec 31, 2019 | 805.00M | 33.72% |
| Dec 31, 2018 | 602.00M | -21.51% |
| Dec 29, 2017 | 767.00M | 149.67% |
| Dec 30, 2016 | 307.20M | 188.72% |
| Dec 31, 2015 | 106.40M | -40.53% |
| Jun 25, 2015 | 178.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elanco Animal Health | 11.63B |
| Regencell Bioscience Holdings | 11.22B |
| Hims & Hers Health | 5.67B |
| Alkermes | 4.67B |
| Amneal Pharmaceuticals | 3.76B |
| Kiniksa Pharmaceuticals International, | 3.56B |
| Liquidia | 3.15B |
| Supernus Pharmaceuticals | 2.88B |